| Literature DB >> 28740615 |
Kyle Parcella1, Kyle Eastman1, Kap-Sun Yeung1, Katharine A Grant-Young1, Juliang Zhu1, Tao Wang1, Zhongxing Zhang1, Zhiwei Yin1, Dawn Parker1, Kathy Mosure1, Hua Fang1, Ying-Kai Wang1, Julie Lemm1, Xiaoliang Zhuo1, Umesh Hanumegowda1, Mengping Liu1, Karen Rigat1, Maria Donoso1, Maria Tuttle1, Tatyana Zvyaga1, Zuzana Haarhoff1, Nicholas A Meanwell1, Matthew G Soars1, Susan B Roberts1, John F Kadow1.
Abstract
Iterative structure-activity analyses in a class of highly functionalized furo[2,3-b]pyridines led to the identification of the second generation pan-genotypic hepatitis C virus NS5B polymerase primer grip inhibitor BMT-052 (14), a potential clinical candidate. The key challenge of poor metabolic stability was overcome by strategic incorporation of deuterium at potential metabolic soft spots. The preclinical profile and status of BMT-052 (14) is described.Entities:
Keywords: Hepatitis C virus; NS5B polymerase; azabenzofuran; deuterium; metabolic stability; primer grip
Year: 2017 PMID: 28740615 PMCID: PMC5512134 DOI: 10.1021/acsmedchemlett.7b00211
Source DB: PubMed Journal: ACS Med Chem Lett ISSN: 1948-5875 Impact factor: 4.345